Development of a Disease Registry for Autoimmune Bullous Diseases: Initial Analysis of The Pemphigus Vulgaris Subset

Acta Dermato-Venereologica

Volumn 95, Issue 1, 2015, Pages 86-90

  Shah, Amit Aakash ^a   Seiffert Sinha, Kristina ^a   Sirois, David ^b   Werth, Victoria P ^c,d   Rengarajan, Badri ^e   Zrnchik, William ^f   Attwood, Kristopher ^g   Sinha, Animesh A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^c Philadelphia VA Medical Center   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e Archimedes Inc   (United States)

^f International Pemphigus Pemphigoid Foundation   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Autoimmune bullous disease; Disease registry; Epidemiology; Pemphigus vulgaris

Indexed keywords

ADOLESCENT; ADULT; AGED; AUTOIMMUNITY; CHILD; CLINICAL TRIAL; COMORBIDITY; DELAYED DIAGNOSIS; DISEASE COURSE; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MULTICENTER STUDY; PEMPHIGUS; PREDICTIVE VALUE; PRESCHOOL CHILD; PROGRAM DEVELOPMENT; QUESTIONNAIRE; RECURRENT DISEASE; REGISTER; REMISSION; RISK FACTOR; SEX DIFFERENCE; TIME; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DELAYED DIAGNOSIS; DISEASE PROGRESSION; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; PREDICTIVE VALUE OF TESTS; PROGRAM DEVELOPMENT; QUESTIONNAIRES; RECURRENCE; REGISTRIES; REMISSION INDUCTION; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84918832878     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1854     Document Type: Article

References (31)

1. Pan M, Liu X, Zheng J. The pathogenic role of autoantibodies in pemphigus vulgaris. Clin Exp Dermatol 2011; 36: 703-707.
2. Tsunoda K, Ota T, Saito M, Hata T, Shimizu A, Ishiko A, et al. Pathogenic relevance of IgG and IgM antibodies against desmoglein 3 in blister formation in pemphigus vulgaris. Am J Pathol 2011; 179: 795-806.
3. Asilian A, Yoosefi A, Faghini G. Pemphigus vulgaris in Iran: epidemiology and clinical profile. Skinmed 2006; 5: 69-71.
4. Kumar KA. Incidence of pemphigus in Thrissur district, south India. Indian J Dermatol Venereol Leprol 2008; 74: 349-351.
5. Hahn-Ristic K, Rzany B, Amagai M, Brocker EB, Zillikens D. Increased incidence of pemphigus vulgaris in southern Europeans living in Germany compared with native Germans. J Eur Acad Dermatol Venereol 2002; 16: 68-71.
6. Heymann AD, Chodick G, Kramer E, Green M, Shalev V. Pemphigus variant associated with penicillin use: a casecohort study of 363 patients from Israel. Arch Dermatol 2007; 143: 704-707.
7. Drago F, Cacciapuoti M, Basso M, Parodi A, Rebora A. Pemphigus improving with gluten-free diet. Acta Derm Venereol 2005; 85: 84-85.
8. Goldberg I, Sasson O, Brenner S. A case of phenol-related contact pemphigus. Dermatology 2001; 203: 355-356.
9. Brenner S, Tur E, Shapiro J, Ruocco V, D'Avino M, Ruocco E, et al. Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol 2001; 40: 562-569.
10. Mimouni D, Bar H, Gdalevich M, Katzenelson V, David M. Pemphigus - analysis of epidemiological factors in 155 patients. J Eur Acad Dermatol Venereol 2008; 22: 1232-1235.
11. Salmanpour R, Shahkar H, Namazi MR, Rahman-Shenas MR. Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991-2000). Int J Dermatol 2006; 45: 103-105.
12. Michailidou EZ, Belazi MA, Markopoulos AK, Tsatsos MI, Mourellou ON, Antoniades DZ. Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: retrospective study of 129 patients. Int J Dermatol 2007; 46: 356-361.
13. Gupta VK, Kelbel TE, Nguyen D, Melonakos KC, Murrell DF, Xie Y, et al. A globally available internet-based patient survey of pemphigus vulgaris: epidemiology and disease characteristics. Dermatol Clin 2011; 29: 393-404, vii-iii.
14. Anonymous. Anthropometric reference data for children and adults: United States, 2007-2010. Hyattsville, Md.: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2012.
15. Murrell DF, Dick S, Ahmed AR, Amagai M, Barnadas MA, Borradori L, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol 2008; 58: 1043-1046.
16. Sardu C, Cocco E, Mereu A, Massa R, Cuccu A, Marrosu MG, et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS One 2012; 7: e32487.
17. Cojocaru M, Cojocaru IM, Silosi I. Multiple autoimmune syndrome. Maedica 2010; 5: 132-134.
18. Somers EC, Thomas SL, Smeeth L, Hall AJ. Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? Am J Epidemiol 2009; 169: 749-755.
19. Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009; 33: 197-207.
20. Brenner S, Wohl Y. A survey of sex differences in 249 pemphigus patients and possible explanations. Skinmed 2007; 6: 163-165.
21. Gonzalez DA, Diaz BB, Rodriguez Perez Mdel C, Hernandez AG, Chico BN, de Leon AC. Sex hormones and autoimmunity. Immunol Lett 2010; 133: 6-13.
22. Ortona E, Margutti P, Matarrese P, Franconi F, Malorni W. Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmun Rev 2008; 7: 579-584.
23. Walker SE. Estrogen and autoimmune disease. Clin Rev Allergy Immunol 2011; 40: 60-65.
24. Satyam A, Khandpur S, Sharma VK, Sharma A. Involvement of T(H)1/T(H)2 cytokines in the pathogenesis of autoimmune skin disease - pemphigus vulgaris. Immunol Invest 2009; 38: 498-509.
25. Gleicher N, Barad DH. Gender as risk factor for autoimmune diseases. J Autoimmun 2007; 28: 1-6.
26. Leshem YA, Katzenelson V, Yosipovitch G, David M, Mimouni D. Autoimmune diseases in patients with pemphigus and their first-degree relatives. Int J Dermatol 2011; 50: 827-831.
27. Kimball AB, Resneck JS, Jr. The US dermatology workforce: a specialty remains in shortage. J Am Acad Dermatol 2008; 59: 741-745.
28. Resneck J, Jr., Pletcher MJ, Lozano N. Medicare, Medicaid, and access to dermatologists: the effect of patient insurance on appointment access and wait times. J Am Acad Dermatol 2004; 50: 85-92.
29. Ladwig KH, Marten-Mittag B, Formanek B, Dammann G. Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol 2000; 16: 511-518.
30. Redondo-Sendino A, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F. Gender differences in the utilization of health-care services among the older adult population of Spain. BMC Public Health 2006; 6: 155.
31. Sirois DA, Fatahzadeh M, Roth R, Ettlin D. Diagnostic patterns and delays in pemphigus vulgaris: experience with 99 patients. Arch Dermatol 2000; 136: 1569-1570.